SEMENZATO, GIANPIETRO CARLO

SEMENZATO, GIANPIETRO CARLO  

Mostra records
Risultati 1 - 20 di 775 (tempo di esecuzione: 0.054 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
CK2β-regulated signaling controls B cell differentiation and function 2023 Quotti Tubi L.Mandato E.Canovas Nunes S.Arjomand A.Zaffino F.Manni S.Casellato A.Macaccaro P.Vitulo N.Zumerle S.Viola A.Valle G.Pizzi M.Dei Tos A. P.Trentin L.Semenzato G.Piazza F. + FRONTIERS IN IMMUNOLOGY - -
IDH2R172 mutation in angioimmunoblastic T-cell lymphoma: A retrospective multicenter case series 2023 Riva M.D'Amore E. S. G.Pizzi M.Parisi A.Semenzato G.Trentin L.Visco C.Piazza F. + EUROPEAN JOURNAL OF HAEMATOLOGY - -
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature 2023 Visentin, AndreaTrentin, LivioSemenzato, Gianpietro + BRITISH JOURNAL OF HAEMATOLOGY - -
A bone-based 3D scaffold as an in-vitro model of microenvironment–DLBCL lymphoma cell interaction 2022 Ceccato J.Piazza M.Pizzi M.Manni S.Piazza F.Caputo I.Cinetto F.Pisoni L.Scarpa R.Zambello R.Tos A. P. D.Trentin L.Semenzato G.Vianello F. + FRONTIERS IN ONCOLOGY - -
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma 2022 Fregnani, AnnaSaggin, LaraGianesin, KettyQuotti Tubi, LauraCarraro, MarcoScapinello, GretaBonetto, GiorgiaPesavento, MariaBranca, AntonioGurrieri, CarmelaZambello, RenatoSemenzato, GianpietroTrentin, LivioManni, SabrinaPiazza, Francesco + CANCERS - -
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation 2022 Teramo, AntonellaBinatti, AndreaCalabretto, GiuliaVicenzetto, CristinaGasparini, Vanessa RebeccaFacco, MonicaBortoluzzi, StefaniaSemenzato, GianpietroZambello, Renato + NATURE COMMUNICATIONS - -
Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia 2022 Teramo A.Gasparini V. R.Vicenzetto C.Calabretto G.Facco M.Semenzato G.Zambello R. + BLOOD CANCER JOURNAL - -
Interrogating molecular genetics to refine LGLL classification 2022 Semenzato, GianpietroZambello, Renato BLOOD - -
Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model 2022 Severin F.Urbani A.Varanita T.Bachmann M.Azzolini M.Martini V.Pizzi M.Dei Tos A. P.Frezzato F.Mattarei A.Paradisi C.Zoratti M.Semenzato G. C.Leanza L.Trentin L.Szabo I. + JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH - -
Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma 2022 Manni, SabrinaPesavento, MariaSpinello, ZairaSaggin, LaraArjomand, ArashFregnani, AnnaQuotti Tubi, LauraScapinello, GretaGurrieri, CarmelaSemenzato, GianpietroTrentin, LivioPiazza, Francesco FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY - -
The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation 2022 Visentin, AndreaMauro, Francesca RomanaFrezzato, FedericaGargarella, Leila RomanoFacco, MonicaPiazza, FrancescoSemenzato, GianpietroTrentin, Livio + HAEMATOLOGICA - -
Corrigendum to “Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family” [Redox Biol. 37 (2020 Sep 6) 101705–101721](S2213231720309101)(10.1016/j.redox.2020.101705) 2021 Peruzzo R.Mattarei A.Azzolini M.Romio M.Rigoni G.Carrer A.Biasutto L.Parrasia S.Urbani A.Rossa A.Semenzato G.Soriano M. E.Trentin L.Paradisi C.Zoratti M.Leanza L.Szabo I. + REDOX BIOLOGY - -
Enhanced IL-9 secretion by p66Shc-deficient CLL cells modulates the chemokine landscape of the stromal microenvironment 2021 Frezzato, F.Visentin, A.Trentin, L.Semenzato, G. + BLOOD - -
GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis 2021 Cinetto F.Ceccato J.Caputo I.Cangiano D.Montini B.Lunardi F.Piazza M.Agostini C.Calabrese F.Semenzato G.Rattazzi M.Gurrieri C.Scarpa R.Felice C.Vianello F. FRONTIERS IN MOLECULAR BIOSCIENCES - -
Hypomethylating agents (Hmas) as salvage therapy in relapsed or refractory aml: An italian multicentric retrospective study 2021 Lessi F.Semenzato G.Trentin L. + BIOMEDICINES - -
Lack of Viral Load Within Chronic Lymphoproliferative Disorder of Natural Killer Cells: What Is Outside the Leukemic Clone? 2021 Giussani, EdoardoBinatti, AndreaCalabretto, GiuliaGasparini, Vanessa RebeccaTeramo, AntonellaVicenzetto, CristinaBarilà, GregorioFacco, MonicaCoppe, AlessandroSemenzato, GianpietroBortoluzzi, StefaniaZambello, Renato FRONTIERS IN ONCOLOGY - -
Large granular lymphocyte leukemia 2021 Teramo A.Vicenzetto C.Barilà GregorioCalabretto G.Gasparini V. R.Semenzato G.Zambello R. - HEMATOLOGIC MALIGNANCIES Hematologic Malignancies
Neutropenia and large granular lymphocyte leukemia: From pathogenesis to therapeutic options 2021 Calabretto G.Teramo A.Vicenzetto C.Gasparini V. R.Semenzato G.Zambello R. + CELLS - -
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis 2021 Cavazzini F.Binotto G.Bosi C.Scaffidi L.Semenzato G.Iurlo A. + BLOOD CANCER JOURNAL - -
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome 2021 Cavazzini F.Iurlo A.Binotto G.Scaffidi L.Bosi C.Semenzato G. + CANCER - -